Inovio Pharmaceuticals Priced An Underwritten Public Offering Of 10M Shares And Accompanying Warrants To Purchase 10M Shares At An Exercise Price Of $3.76/Share, At A Combined Public Offering Price Of $3/Share And Accompanying Warrant, With Gross...
Inovio Pharmaceuticals Priced An Underwritten Public Offering Of 10M Shares And Accompanying Warrants To Purchase 10M Shares At An Exercise Price Of $3.76/Share, At A Combined Public Offering Price Of $3/Share And Accompanying Warrant, With Gross...
伊诺维奥制药定价了一项承销的公开发行，发行1000万股股份及相应的Warrants，以每股3.76美元的执行价格购买1000万股股份，公开发行的综合价格为每股3美元及相应的Warrant，毛收入...
Inovio Pharmaceuticals Priced An Underwritten Public Offering Of 10M Shares And Accompanying Warrants To Purchase 10M Shares At An Exercise Price Of $3.76/Share, At A Combined Public Offering Price Of $3/Share And Accompanying Warrant, With Gross Proceeds Of $30M
伊诺维奥制药以每股3美元的公众发售价格，定价1,000万股的承销公开发行及伴随的Warrants，购买1,000万股，行使价格为每股3.76美元，预计总收益为3000万美元。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。